DB15862InvestigationalVaccines
Developed by Sinopharm's Wuhan Institute of Biological Products co., this vaccine consists of the WIV04 strain of SARS-CoV-2. This strain was isolated from a patient in Wuhan, cultivated in a... This strain was isolated from a patient in Wuhan, cultivated in a Vero cell line, and then subsequently inactivated using B-propiolactone.
- Code names
- Inactivated SARS-Cov-2 Vaccine
What you can answer from here — as of February 03, 2022
Which companies are running trials of Inactivated SARS-Cov-2 Vaccine, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account